Frequency and Prognosis of JAK2 V617F, Calr, MPL and ASXL1 Mutations in Primary Myelofibrosis

被引：0

作者：

Sorigue, Marc ^{[1
]}

Cabezon, Marta ^{[2
]}

Garcia, Olga ^{[1
]}

Velez, Patricia ^{[3
]}

Marce, Silvia ^{[2
]}

Boque, Concha ^{[3
]}

Xicoy, Blanca ^{[1
]}

Fernandez, Cristalina ^{[4
]}

Xandri, Marisol ^{[2
]}

Casanova, Enric ^{[3
]}

Gallardo, David ^{[4
]}

Milla, Fuensanta ^{[2
]}

Ribera, Josep-Maria ^{[2
]}

Feliu, Evarist ^{[2
]}

Zamora, Lurdes ^{[2
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, ICO, Josep Carreras Leukemia Res Inst, Badalona, Spain

[2] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, ICO Badalona, Josep Carreras Leukemia Res Inst, Badalona, Spain

[3] Hosp Duran y Reynals, ICO, Lhospitalet De Llobregat, Spain

[4] Hosp Josep Trueta, ICO, Girona, Spain

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] JAK2 mutations (V617F and exon 12) in children with erythrocytosis
Randi, M. L.
Scapin, M.
Pacquola, E.
Duner, E.
Scandellari, R.
Bonato, S.
Putti, M. C.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 88 - 88
[42] JAK2, the JAK2 V617F mutant and cytokine receptors
Staerk, J.
Kallin, A.
Royer, Y.
Diaconu, C. C.
Dusa, A.
Demoulin, J.-B.
Vainchenker, W.
Constantinescu, S. N.
PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
[43] Neutrophilia and the JAK2 V617F Mutation
Langabeer, Stephen E.
Haslam, Karl
PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
[44] Splenomegaly and the JAK2 V617F mutation
Langabeer, Stephen E.
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
[45] FREQUENCY OF JAK2 EXON 12 MUTATIONS IN JAK2 (V617F) NEGATIVE PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISORDERS (CMD)
Bernardi, M.
Ruggeri, M.
Albiero, E.
Madeo, D.
Rodeghiero, F.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 294 - 294
[46] The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience
Najm, Maysam Basim
Jalal, Sana Dlawar
Getta, Hisham Arif
CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (08) : 202 - 209
[47] Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients
Limsuwanachot, N.
Rerkamnuaychoke, B.
Chuncharunee, S.
Pauwilai, T.
Singdong, R.
Rujirachaivej, P.
Chareonsirisuthigul, T.
Siriboonpiputtana, T.
HEMATOLOGY, 2017, 22 (10) : 599 - 606
[48] JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort
McGaffin, Gillian
Harper, Kirsteen
Stirling, David
McLintock, Lorna
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (02) : 276 - 278
[49] Cutaneous Myelofibrosis With JAK2 V617F Mutation: Metastasis, Not Merely Extramedullary Hematopoiesis!
Fraga, Garth R.
Caughron, Samuel K.
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2010, 32 (07) : 727 - 730
[50] ASXL1 mutations in primary and secondary myelofibrosis
Ricci, Clara
Spinelli, Orietta
Salmoiraghi, Silvia
Finazzi, Guido
Carobbio, Alessandra
Rambaldi, Alessandro
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 404 - 407

← 1 2 3 4 5 →